News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Max Julvé: Toxicity management strategies for solid tumour cell therapy
Max Julvé/X
Jan 6, 2025, 13:02

Max Julvé: Toxicity management strategies for solid tumour cell therapy

Max Julvé, Clinical Research Fellow at The Royal Marsden NHS Foundation Trust, shared a post about a recent paper by him and colleagues published in ESMO IOTECH:

“Delighted to share our new paper reviewing toxicity management strategies for solid tumour cell therapy in ESMO IOTECH. A great team effort from Sophia Wong, Jon Lim, and Andrew Furness.”

“Solid tumour cellular therapy — principles of toxicity management”

Authors: Max Julvé, Sophia Wong, Jonathan Lim, Andrew Furness.

Max Julvé: Toxicity management strategies for solid tumour cell therapy

Andrew Furness cancer Cell Therapy ESMO IOTECH Jon Lim Max Julvé OncoDaily Oncology solid tumour Sophia Wong Toxicity management
Special Coverage
Science
Jan 6, 2025, 13:02
Max Julvé: Toxicity management strategies for solid tumour cell therapy
Science
Jan 6, 2025, 12:59
Arndt Vogel: The use of immunotherapy pre-liver transplant
Science
Jan 6, 2025, 12:40
Chaitanya Bandlamudi: Detailed clinico-genomic landscape of pancreatic adenocarcinomas
Science
Jan 6, 2025, 12:37
Sharlene Gill: Adjuvant immunotherapy in patients with resected ESO/GEJ cancer
Career
Jan 6, 2025, 12:35
Kicking of exciting new season of Inside Cancer Careers with LeeAnn Bailey - Train at NCI
Blog
Jan 6, 2025, 12:33
Revolutionizing Cancer Care - Canary Oncoceutics
Blog
Jan 6, 2025, 12:31
Banu Arun: Pioneering New Horizons in BRCA-Positive Breast Cancer Treatment
Blog
Jan 6, 2025, 12:31
Raising Radon Awareness - ALCSI
Insight
Jan 6, 2025, 12:28
We are proud to be the first non-profit 100% dedicated to Myelodysplastic Syndromes - MDS Foundation
Insight
Jan 6, 2025, 12:15
Erman Akkus: Adjuvant pembrolizumab after surgery in high risk muscle invasive bladder cancer
Blog
Jan 6, 2025, 11:56
Julie Gerberding: Extermely fortunate to benefit from Ellen Sigal’s passionate leadership as a member of FNIH Board
Blog
Jan 6, 2025, 11:54
Pashtoon Kasi: Have to be mindful of rare side effects of Immunotherapy